Consolidation in Cardiac Rhythm Management
Sulzer Medica's decision to sell Intermedics Inc. was as much a statement about the difficulty of resurrecting its pacemaker business as it was of the company's desire to concentrate on its core orthopedic and cardiovascular prosthetic lines. Guidant Corp. is a natural acquirer. Intermedics helps solidify its position as the number two company in cardiac rhythm management.
You may also be interested in...
Health technology assessment body NICE says that Revlimid fights cancer cells in a different way to current treatments which should help reduce resistance and improve disease outcomes.
As sector awaits its aducanumab filing with bated breath, Biogen invests again in early stage neuroscience.
In case you missed it: catch up with snippets from interviews with industry leaders recently published by In Vivo.